Answers are grounded in this paper and cite their sources.
Demonstrates hexamethonium delivery to CNS via fullerene C60, suggesting new drug development strategies.
The treatment of various psychiatric and neurodegenerative disorders requires drugs that act directly within the central nervous system. However, many potentially effective compounds cannot cross the blood–brain barrier. Due to its lipophilic nature, fullerene C60 has the potential to carry polar substances. Systems for charged compounds delivery into the CNS can be developed based on amino acid adducts of fullerene. In this work, we synthesized complexes of fullerene adducts with hexamethonium and demonstrated their anticonvulsant activity. This result confirms that the bis quaternary compound can penetrate into the brain when transported by fullerene C60.
No takes yet. Share an insight, caveat, or question.
Litasova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: